Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • AJNR Case Collection
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • Special Collections
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
    • 2024 AJNR Journal Awards
    • Most Impactful AJNR Articles
  • Multimedia
    • AJNR Podcast
    • AJNR Scantastics
    • Video Articles
  • For Authors
    • Submit a Manuscript
    • Author Policies
    • Fast publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Manuscript Submission Guidelines
    • Imaging Protocol Submission
    • Submit a Case for the Case Collection
  • About Us
    • About AJNR
    • Editorial Board
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Other Publications
    • ajnr

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • AJNR Case Collection
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • Special Collections
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
    • 2024 AJNR Journal Awards
    • Most Impactful AJNR Articles
  • Multimedia
    • AJNR Podcast
    • AJNR Scantastics
    • Video Articles
  • For Authors
    • Submit a Manuscript
    • Author Policies
    • Fast publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Manuscript Submission Guidelines
    • Imaging Protocol Submission
    • Submit a Case for the Case Collection
  • About Us
    • About AJNR
    • Editorial Board
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

Welcome to the new AJNR, Updated Hall of Fame, and more. Read the full announcements.


AJNR is seeking candidates for the position of Associate Section Editor, AJNR Case Collection. Read the full announcement.

 

OtherPEDIATRICS

Severe Tacrolimus Leukoencephalopathy after Liver Transplantation

Janneke Schuuring, Pieter Wesseling and Aad Verrips
American Journal of Neuroradiology November 2003, 24 (10) 2085-2088;
Janneke Schuuring
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pieter Wesseling
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aad Verrips
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Abstract

Summary: Tacrolimus is an immunosuppressive agent that can show a wide variety of neurologic side effects, including leukoencephalopathy. Although the prognosis is good—after cessation or dose reduction, complete recovery usually occurs—the differentiation with treatable diseases such as progressive multifocal encephalopathy can be difficult, making a stereotactic biopsy of the white matter lesion sometimes necessary. We describe the case of a 12-year-old girl with a severe, reversible tacrolimus-related leukoencephalopathy and only mild histopathologic abnormalities.

Tacrolimus (FK-506) is an immunosuppressive agent frequently used after organ transplantation. A wide variety of neurologic side effects has been described, resembling those in cyclosporine therapy (1). Although they are reported to be minor (headache, tremor, paresthesia) in most organ transplant patients, major neurotoxicity, such as leukoencephalopathy, develops in 1–6% of transplant recipients (2). So far, the etiology is unknown. There is no absolute relationship between the serum tacrolimus level and the occurrence or severity of neurologic symptoms, but high levels are often found with neurologic improvement on dose reduction (2).

Neurologic symptoms and signs are usually manifested soon after transplantation. In 82% of the affected patients with leukoencephalopathy, this complication is reported to occur within 3 months after transplantation and even earlier in liver transplant recipients (2). MR imaging may reveal white matter lesions predominantly in the posterior cerebral regions (3). To our knowledge, there is only one previous report with histopathologic analysis of tacrolimus leukoencephalopathy: the white matter was described to show small areas of demyelination, which were associated with veins and with sparing of axons in these areas (4).

Other causes of white matter lesions, especially opportunistic infections such as progressive multifocal leukoencephalopathy (PML) can be difficult to exclude, and in some cases a biopsy of the lesion is indicated.

We present a case of extensive leukoencephalopathy as a relatively late complication of tacrolimus therapy in which serum drug levels were normal and no concomitant disease existed. The severe clinical and radiologic presentation contrasts with the mild histopathologic findings.

Case Report

A 12-year-old girl underwent an orthotopic liver transplantation in March 1999 and received tacrolimus 3 mg daily and prednisolon 15 mg daily. For 6 weeks after transplantation, she was hypertensive. Thereafter she remained normotensive with medication. Six months after transplantation, she had a focal, secondary generalizing seizure. Within 2 minutes, the seizure stopped. Blood pressure was normal. Neurologic examination revealed a left-sided hemiplegia including an extensor plantar response and a tremor of both hands. Laboratory findings, including liver and renal function, cholesterol, magnesium, and CSF were normal. Polymerase chain reaction analysis for JC virus in the CSF was negative. Tacrolimus blood level was within therapeutic range; 14.9 ng/mL (normal values 5–20 ng/mL). On the cerebral CT scan, the subcortical white matter was hypoattenuated (Fig 1A). MR imaging 1 day after presentation showed extensive white matter lesions on T2-weighted images, without gadolinium enhancement or decreased signal intensity on T1-weighted images (Fig 1B–F). Because of the late occurrence, the lesion extent, and the possibility that a treatable disorder such as PML might be overlooked, a stereotactic biopsy was performed after 2 weeks. After microscopic examination of the biopsy that did not show features of infection, diagnosis of tacrolimus-induced leukoencephalopathy was made (Fig 2A and B). After a decrease in tacrolimus dosage, the white matter lesions gradually disappeared (Fig 1G–H). Clinical recovery was complete within 5 months. At that time, MR imaging showed only mild cerebral white matter lesions (Fig 1J and K). During 3 years of follow-up, she has had no neurologic sequelae and has retained normal liver function.

Fig 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 1.

Radiographic findings in a 12-year-old girl with a severe, reversible tacrolimus-related leukoencephalopathy.

A, Cerebral CT scan shows extensive subcortical hypoattenuation in both parietal regions (canthus-meatus plane, without contrast).

B, T1-weighted MR image obtained in the acute phase (day 1) shows no gadolinium enhancement or decreased signal intensity (5 mm slices, TR 760, TE 15/1, TA 03:42).

C–F, T2-weighted MR images obtained in the acute phase (day 1) show hyperintense lesions in the parietal white matter (C), periventricular white matter (D), cerebellum (E), and brainstem (F) (5 mm slices, TR 3100, TE 98/2, TA 04:03).

G–I, T2-weighted MR images obtained 18 days later (day 19), after a dose reduction of tacrolimus and stereotactic biopsy 6 days earlier, show a remarkable decrease in the hyperintense lesions in the parietal white matter (G). The hyperintense lesions in the cerebellar white matter and brain stem (H) have disappeared. Note the biopsy lesion (I) (5 mm slices, TR 3100, TE 98/2, TA 04:03).

J and K, T2-weighted MR images obtained 5 months after G–I show only a mild right-sided hyperintense lesion (J). In the left hemisphere, the biopsy lesion resides (K) (5 mm slices, TR 3100, TE 98/2, TA 04:03).

Fig 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 2.

Biopsy specimens.

A, In the biopsy fragments, the cerebral white matter shows a normal aspect with ample staining for myelin, absence of inflammatory infiltrate and (in contrast to PML) absence of enlarged nuclei of glial cells. Occasional perivascular macrophages (arrow), however, contain granular, blue-staining material, consistent with myelin debris. (Combined Luxol Fast Blue and Hematoxylin-Eosin staining; original magnification ×630).

B, Electron microscopy, performed on material retrieved from the paraffin block, reveals multilamellar particles in the perivascular macrophages, corroborating the myelin nature of these granules.

Discussion

Leukoencephalopathy is a complication of tacrolimus use in both adults and children and is usually reversible after dose reduction of tacrolimus in almost all patients when diagnosed promptly (5).

The pathophysiologic basis for tacrolimus neurotoxicity is unknown. Factors that are reported to facilitate neurotoxicity are systemic hypertension, high-dose corticosteroid therapy, serum hypocholesterolemia, hypomagnesemia, aluminum overload, and hepatic encephalopathy (2). In our patient, high-dose corticosteroid therapy might have contributed to the leukoencephalopathy, whereas the contribution of hypertension seems less likely, because it was successfully treated.

Tacrolimus is a lipophilic agent that crosses the blood-brain barrier and, like cyclosporine, may have a direct neurotoxic effect, especially on the lipid-rich white matter (6). Furthermore, cyclosporine is known to cause axonal swelling, but this effect has not yet been described for tacrolimus use (5).

Our patient had one focal, secondary generalizing seizure lasting less than 2 minutes. This was the single epileptic event. Seizures may lead to transient MR signal intensity changes themselves (7, 8). Because of the lack of MR imaging findings of involvement of cortical structures, the extent of the lesions, and the absence of a prolonged epileptic event, we find that the convulsion cannot be responsible for the white matter lesions.

In most patients with tacrolimus-related leukoencephalopathy, a biopsy procedure is not considered to be necessary when after cessation or dose reduction of tacrolimus the clinical condition improves. In our patient, however, the lesions were very extensive and occurred relatively late after transplantation. Therefore other diseases, especially PML, had to be considered. In the only previous histopathologic report of tacrolimus leukoencephalopathy, focal, predominantly perivenous demyelination was found (4). In our patient, stereotactic biopsy findings of cerebral white matter showed, by light microscopy, a normal structure and staining for myelin (Fig 2A), but occasional perivascular macrophages containing lamellar bodies consistent with myelin debris were present (Fig 2A and B).

Conclusion

We conclude that leukoencephalopathy is a serious complication of tacrolimus use that can be completely reversible after dose decrement. Although at the radiologic level a predilection for the posterior cerebral white matter has been reported, the lesions may be much more extensive. The relatively mild histologic findings and the reversibility of the clinical syndrome indicate that these impressive radiologic changes are, at least in an early phase, in large part the result of reversible edema instead of destructive structural alterations.

References

  1. ↵
    McDiarmid SV, Busuttil RW, Ascher NL, et al. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Transplantation 1995;59:530–536
    PubMed
  2. ↵
    Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 2000;69:467–472
    CrossRefPubMed
  3. ↵
    Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500
    CrossRefPubMed
  4. ↵
    Small SL, Fukui MB, Bramblett GT, et al. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506). Ann Neurol 1996;40:575–580
    CrossRefPubMed
  5. ↵
    Torocsik HV, Curless RG, Post J, et al. FK506-induced leukoencephalopathy in children with organ transplants. Neurology 1999;52:1497–1500
    Abstract/FREE Full Text
  6. ↵
    Kochi S, Takanaga H, Matsuo H, et al. Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells. Eur J Pharmacol 1999;372:287–295
    CrossRefPubMed
  7. ↵
    Kim J, Chung J, Yoon P, et al. Transient MR signal changes in patients with generalized tonicoclonic seizure or status epilepticus: periictal diffusion-weighted imaging. AJNR Am J Neuroradiol 2001;22:1149–1160
    Abstract/FREE Full Text
  8. ↵
    Dillon W, Rowley H. The reversible posterior cerebral edema syndrome. AJNR Am J Neuroradiol 1998;19:591
    PubMed
  • Received December 19, 2002.
  • Accepted after revision April 6, 2002.
  • Copyright © American Society of Neuroradiology
View Abstract
Back to top

In this issue

American Journal of Neuroradiology: 24 (10)
American Journal of Neuroradiology
Vol. 24, Issue 10
1 Nov 2003
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Severe Tacrolimus Leukoencephalopathy after Liver Transplantation
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
Janneke Schuuring, Pieter Wesseling, Aad Verrips
Severe Tacrolimus Leukoencephalopathy after Liver Transplantation
American Journal of Neuroradiology Nov 2003, 24 (10) 2085-2088;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Severe Tacrolimus Leukoencephalopathy after Liver Transplantation
Janneke Schuuring, Pieter Wesseling, Aad Verrips
American Journal of Neuroradiology Nov 2003, 24 (10) 2085-2088;
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Case Report
    • Discussion
    • Conclusion
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Acute Toxic Leukoencephalopathy: Etiologies, Imaging Findings, and Outcomes in 101 Patients
  • Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study
  • Posterior Reversible Encephalopathy Syndrome in Patients With Cancer
  • Posterior reversible encephalopathy syndrome: the importance of early diagnosis
  • Reversible Encephalopathy after Cardiac Transplantation: Histologic Evidence of Endothelial Activation, T-Cell Specific Trafficking, and Vascular Endothelial Growth Factor Expression
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Comparison of Image Quality and Radiation Dose in Pediatric Temporal Bone CT Using Photon-Counting Detector CT and Energy-Integrating Detector CT
  • SyMRI & MR Fingerprinting in Brainstem Myelination
  • Axenfeld-Rieger Syndrome: Neuroimaging Findings
Show more Pediatrics

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editors Choice
  • Fellow Journal Club
  • Letters to the Editor

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

Special Collections

  • Special Collections

Resources

  • News and Updates
  • Turn around Times
  • Submit a Manuscript
  • Author Policies
  • Manuscript Submission Guidelines
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Submit a Case
  • Become a Reviewer/Academy of Reviewers
  • Get Peer Review Credit from Publons

Multimedia

  • AJNR Podcast
  • AJNR SCANtastic
  • Video Articles

About Us

  • About AJNR
  • Editorial Board
  • Not an AJNR Subscriber? Join Now
  • Alerts
  • Feedback
  • Advertise with us
  • Librarian Resources
  • Permissions
  • Terms and Conditions

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire